Dopamine decarboxylase inhibitors (DDCIs) are used along with with levodopa to treat Parkinson's disease. They work by preventing levodopa from being turned into dopamine in the body before it reaches your brain. Most DDCIs are included in combination medications that also contain levodopa. The most common DDCI is carbidopa (Lodosyn).